These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3034757)

  • 1. Enhanced response of plasma prolactin to metoclopramide during chronic converting enzyme inhibition.
    Dupont AG; Van der Nipen P; Van Steirteghem AC; Vanhaelst L
    Horm Metab Res; 1987 May; 19(5):212-5. PubMed ID: 3034757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic control of aldosterone secretion in hypertensive patients chronically treated with an angiotensin converting enzyme inhibitor.
    Waeber B; Nussberger J; Schaller MD; Gomez HJ; Brunner HR
    Horm Metab Res; 1986 Jan; 18(1):60-3. PubMed ID: 3005150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of aldosterone secretion by metoclopramide is not affected by chronic converting enzyme inhibition.
    Dupont AG; Vanderniepen P; Smitz JJ; Six RO
    Eur J Clin Pharmacol; 1985; 29(2):207-10. PubMed ID: 3000795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1979 Apr; 63(4):727-35. PubMed ID: 438333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
    Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A
    Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of enalapril on renin, angiotensin converting enzyme activity, aldosterone and prostaglandins in patients with hypertension.
    Larochelle P; Gutkowska J; Schiffrin E; Kuchel O; Hamet P; Genest J
    Clin Invest Med; 1985; 8(3):197-201. PubMed ID: 2994932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
    Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
    J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
    Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
    McCaa RE; Gillespie JB
    Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dietary sodium on angiotensin-converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril (MK-421) in essential hypertension.
    Jackson B; Cubela R; Johnston CI
    J Hypertens; 1984 Aug; 2(4):371-7. PubMed ID: 6099390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological effects of short-term treatment with enalapril in hypertensive patients.
    de Leeuw PW; Hoogma RP; van Soest GA; van Es PN; Birkenhäger WH
    J Hypertens Suppl; 1983 Oct; 1(1):87-91. PubMed ID: 6100612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade.
    Biollaz J; Brunner HR; Gavras I; Waeber B; Gavras H
    J Cardiovasc Pharmacol; 1982; 4(6):966-72. PubMed ID: 6185790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
    Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of bromocriptine on renin, aldosterone, and prolactin responses to posture and metoclopramide in idiopathic edema: possible therapeutic approach.
    Sowers J; Catania R; Paris J; Tuck M
    J Clin Endocrinol Metab; 1982 Mar; 54(3):510-6. PubMed ID: 7035482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The importance of studying the renin-angiotensin-aldosterone system in essential arterial hypertension in clinical practice. Activity of the renin-angiotensin-aldosterone system during treatment of hypertension with ACE-inhibitors and beta blockers].
    Hrnciar J; Hrnciarová M; Lepej J; Okálová D; Kreze A; Chamulová M
    Vnitr Lek; 1994 Sep; 40(9):557-62. PubMed ID: 7975357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enalapril decreases plasma prolactin levels in hypertensive patients.
    Lombardi C; Missale C; De Cotiis R; Spano PF
    J Biol Regul Homeost Agents; 1989; 3(3):128-30. PubMed ID: 2560316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enalaprilat: an intravenous substitute for oral enalapril therapy. Humoral and pharmacokinetic effects.
    Reams GP; Lal SM; Whalen JJ; Bauer JH
    J Clin Hypertens; 1986 Sep; 2(3):245-53. PubMed ID: 3023555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of prostaglandins in the antihypertensive effect of the converting enzyme inhibitor, enalapril].
    Espinoza F; Gallego A; Ruiz A; Pérez-Grovas H; Garza Flores J; Morato T; Herrera-Acosta J
    Rev Invest Clin; 1989; 41(4):351-60. PubMed ID: 2561022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of angiotensin-converting enzyme inhibition on plasma aldosterone concentration, plasma renin activity, and blood pressure in spontaneously hypertensive cats with chronic renal disease.
    Steele JL; Henik RA; Stepien RL
    Vet Ther; 2002; 3(2):157-66. PubMed ID: 19750747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.